Surmodics | SRDX - Pre Tax Profit


Surmodics reported $-7.51M in Pre-Tax Profit for its fiscal quarter ending in September of 2024.





Pre Tax Profit Change Date
Abbott USD 2.36B 178M Dec/2025
Align Technology USD 176.6M 81.86M Dec/2025
Anika Therapeutics USD -3.87M 32.43M Mar/2025
Arrowhead Research USD 28.27M 7.85M Dec/2025
Artivion USD -1.27M 1.16M Sep/2024
Baxter International USD 121M 12M Sep/2025
Boston Scientific USD 938M 3M Sep/2025
EDAP TMS EUR -4.91M 597K Sep/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Haemonetics USD 59.97M 8.69M Dec/2025
Heron Therapeutics USD -4.85M 4.39M Sep/2024
J&J USD 4.97B 2.53B Dec/2025
Merit Medical Systems USD 73.18M 29.8M Sep/2025
Mesa Laboratories USD -2.22M 6.03M Dec/2024
Nektar Therapeutics USD -37.05M 15.27M Sep/2024
Option Care Health USD 68.97M 109K Sep/2025
Stryker USD 1.03B 13M Sep/2025
Surmodics USD -7.51M 1.69M Sep/2024
Trinity Biotech USD -5.06M 10.74M Sep/2025